期刊文献+

肿瘤标志物的检测及临床应用 被引量:3

下载PDF
导出
摘要 肿瘤是严重威胁人类健康的重大疾病,具有高发病率和高死亡率的特点。大量研究和临床实践证实,早期诊断和早期治疗是防治肿瘤与降低死亡率的最有效方法。近年来,肿瘤标志物在肿瘤的早期检测、鉴别诊断、疗效观察以及预后判断等方面中的作用日益受到关注,肿瘤标志物的研究与应用也取得了较大进展。本文就肿瘤标志物的分类、临床应用及检测等方面予以综述。
作者 刘婷
机构地区 解放军
出处 《当代医学》 2009年第24期24-25,共2页 Contemporary Medicine
  • 相关文献

参考文献4

二级参考文献14

  • 1吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 2中华医学会检验医学分会肿瘤标志物专家委员会.肿瘤标志物检测临床应用的基本原则(讨论稿)[J].中华检验医学杂志,2004,:27-27.
  • 3Kulpa J,Wojcik E,Reinfuss M,et al.Carcinoembryonic antigen,squamous cell carcinoma antigen,CYFRA21-1,and neuron specific enolase in squamous cell lung cancer patients.Clin Chem,2002,48:1931-1937.
  • 4Fizazi K,Cojean I,Pignon JP,et al.Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy:an early predictor of complete response and survival in patients with small cell ling carcinoma.Cancer,1998,82:1049-1055.
  • 5Berek JS, Bast RC. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection [ J ]. Cancer, 1995,76 ( Suppl 10 ) : 2092- 2096.
  • 6Redman CW, Bleckledge GR, Kelly K, et al. Early serum CA125 response and outcome in epithelial ovarian cancer [J].Eur Cancer, 1990, 26:593-596.
  • 7Gadducci A, Zola P, Landoni F, et al. Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study [ J]. Gynecol Oncol, 1995,58 ( 1 ) : 42-47.
  • 8Kurokawa T, Yoshida Y, Kawahara K. Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA125 levels within the normal range [ J ]. Ann Nucl Med,2002, 16(7) :491-493.
  • 9Wilder JL, Pavlik E, Straughan JI, et al. Clinical implications of a rising serum CA125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation [ J ]. Gynecol Oncol, 2003,89 (2) :233-235.
  • 10van der Burg ME, Lammes FB, van Putten WL, et al. Ovarian cancer: the prognostic value of the serum half-time of CA125 during the induction of chemotherapy [ J ]. Gynecol Oncol, 1988, 30(6) :307-312.

共引文献54

同被引文献33

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部